Connect Biopharma Holdings Limited Increase Decrease Through Conversion Of Convertible Instruments
Connect Biopharma Holdings Limited (CNTB) reported Increase Decrease Through Conversion Of Convertible Instruments of CNY 2.74 billion for the 12-month period ending 2021-12-31, per its 20-F filed 2023-04-11.
Discontinued › Notes
ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments · last filed 2024-04-16
CNY
| Period end | Increase Decrease Through Conversion Of Convertible Instruments 6 month | Increase Decrease Through Conversion Of Convertible Instruments 12 month |
|---|---|---|
| 2021-12-31 | 2.74B CNY 20-F · filed 2023-04-11 | |
| 2021-06-30 | 2.74B CNY 6-K · filed 2022-09-13 |
USD
| Period end | Increase Decrease Through Conversion Of Convertible Instruments 12 month |
|---|---|
| 2021-12-31 | $421.46M 20-F · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |